Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|September 5, 2012
[Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: long-term effects and safety]Yi-jun Shen, Xiao-jie Bian, Hu-yang Xie, et al.
Asian Journal of Andrology|August 21, 2012
The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy?Guo-Wen Lin, Xu-Dong Yao, Ding-Wei Ye, et al.
Asian Journal of Andrology|December 4, 2008
Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countriesYi-Ping Zhu, Ding-Wei Ye, Xu-Dong Yao, et al.
Urologia Internationalis|November 23, 2011
Narrow-band imaging flexible cystoscopy in the detection of clinically unconfirmed positive urine cytologyYi-Ping Zhu, Yi-Jun Shen, Ding-Wei Ye, et al.
Asian Journal of Andrology|November 14, 2012
Prognostic factors in Chinese patients with metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapyYuan-Yuan Qu, Bo Dai, Yun-Yi Kong, et al.
Fitoterapia|May 13, 2022
Novel flavonolignans from the roots of Indigofera stachyodesHua-Yong Lou, Ping Yi, Han-Fei Liu, et al.
International Urology and Nephrology|September 4, 2012
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomyHu-Yang Xie, Yao Zhu, Xu-Dong Yao, et al.
The Kaohsiung Journal of Medical Sciences|January 22, 2014
Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancerYi-Ping Zhu, Xu-Dong Yao, Shi-Lin Zhang, et al.
Clinical Genitourinary Cancer|October 13, 2012
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid featureHai-Liang Zhang, Yao Zhu, Xiao-Jian Qin, et al.
The Prostate|September 16, 2010
Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapyHai-Liang Zhang, Li-Feng Yang, Yao Zhu, et al.
Pageof 8